A recent study published in JAMA Oncology suggests that the ideal duration of hormone therapy for patients with localized prostate cancer may depend on a patients’ individual cancer risk, allowing physicians to tailor treatment plans and…
Study: Shorter course of ADT may be sufficient for many patients with prostate cancer
